← FDA DRUG APPROVALS

FDA ANDA · ANDA089892

PHENYTOIN

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION
ANDA089892
TYPE
ANDA
ORIGINAL APPROVAL
1992-09-25
LATEST ACTION
2004-03-10
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

PHENYTOINDiscontinued
PHENYTOIN 125MG/5ML · SUSPENSION · ORAL

Approval history

2004-03-10Labeling · Supplement 17AP
2001-11-13Manufacturing (CMC) · Supplement 12AP
2000-12-18Manufacturing (CMC) · Supplement 9AP
2000-12-18Manufacturing (CMC) · Supplement 8AP
2000-11-02Manufacturing (CMC) · Supplement 11AP
1998-02-09Manufacturing (CMC) · Supplement 6AP
1998-02-09Manufacturing (CMC) · Supplement 5AP
1996-08-07Manufacturing (CMC) · Supplement 4AP
1996-08-07Manufacturing (CMC) · Supplement 2AP
1996-08-07Manufacturing (CMC) · Supplement 3AP
1996-08-07Manufacturing (CMC) · Supplement 1AP
1992-09-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →